A study examining what happens when older patients stop taking cholesterol-lowering drugs has produced a result its authors appear not to have expected, according to Berliner Morgenpost. The German newspaper reported on the findings on Thursday, September 17, 2026.
Coverage of the study across German medical outlets points in two directions. The Deutsches Ärzteblatt reported that atorvastatin therapy did not extend disability-free life in very old patients. Meanwhile, ad-hoc-news.de reported that stopping statins in old age did not raise risk, and PTA IN LOVE framed the same question bluntly: whether statins are better discontinued later in life.
The findings sit alongside separate reporting from aponet.de, which said statins still protect people over 70 against heart attacks and strokes. Taken together, the coverage suggests the picture is more nuanced than a simple case for or against the drugs in elderly patients.
Statins are widely prescribed to lower cholesterol, and the question of when — or whether — to stop them in older age has drawn growing attention. The Berliner Morgenpost described the study's outcome as unexpected, though the available reporting does not detail the study's size, design or the patient group involved.
What to watch next: whether the full study is published with its methods and patient data, and how cardiology and geriatric guidelines respond to the finding.